Status | Study |
Completed |
Study Name: A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ Condition: Ductal Carcinoma in Situ Date: 2012-06-20 Interventions: Dietary Supplement: Black cohosh Remifemin 20 mg tablet orally twice per day x 4 weeks |
Terminated |
Study Name: Diagnostic Study of Early Breast Cancer Using Ultrasound Condition: Ductal Carcinoma In-situ Date: 2011-06-15 Interventions: Drug: Perflutren lipid microsphere Intravenous injection of 10 microL/kg once prior to ultrasound examin |
Completed |
Study Name: Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor Condition: Ductal Carcinoma in Situ Date: 2011-06-09 Interventions: Drug: SOM 230 / Pasireotide SOM230/Pasireotide is a multi-receptor targeted somatostatin analogue. In th |
Terminated |
Study Name: A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ Condition: Ductal Carcinoma in Situ Date: 2010-01-29 Interventions: Drug: Polyphenon E three 200mg capsules (600mg total dose of the study drug) with food (within one hour |
Completed |
Study Name: Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial) Condition: Carcinoma, Intraductal, Noninfiltrating DCIS Date: 2009-12-01 Interventions: Drug: Chloroquine Standard Dose (500mg/week) |
Completed |
Study Name: 4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ Condition: Ductal Breast Carcinoma in Situ Estrogen Receptor-positive Brea Date: 2009-08-04 Interventions: Drug: oral placebo Oral placeb |
Completed |
Study Name: MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ Condition: Breast Cancer Date: 2009-04-01 Interventions: Procedure: magnetic resonance imaging Proc |
Terminated |
Study Name: Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast Condition: Ductal Carcinoma in Situ Date: 2009-03-06 Interventions: Drug: lapatinib 1500 mg lapatinib for 14-21 days Oth |
Not yet recruiting |
Study Name: Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast Condition: Breast Cancer Date: 2008-11-07 Interventions: Drug: vorinostat Genetic: protein expressi |
Active, not recruiting |
Study Name: Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Condition: Ductal Breast Carcinoma In Situ HER2/Neu Positive Date: 2008-10-08 Interventions: Other: Laboratory Biomarker Analysis |